Agn@rph case management

Case Management:Acute Glomerulonephritis

Presentor: Ma. Nieves Elizabeth N. Cruz, MD

Rizal Provincial HospitalRizal Provincial HospitalMay 25, 2010May 25, 2010

1

• J.C., 8/f• Cardona, Rizal

• Admitted: April 22, 2010• Discharged: April 26, 2010

GENERAL DATA

2

CHIEF COMPLAINT

tea-colored-urine

3

HISTORY OF PRESENT ILLNESS

4 days PTA fever, intermittent; resolved with intake of Paracetamol

3 days PTA tea-colored urine dec.urine output

1 day PTA consult with a PMD

RPH

4

PERTINENT P.E. FINDINGS

• Wt = 28kg• Temp = 36°C• BP = 100/70 mmHg• CR = 100 bpm• RR = 23 cpm

5

PERTINENT P.E. FINDINGS

•No pallor•No facial edema•+ clear breath sounds•No respiratory distress•No abdominal distension•No visible lesions/wounds on extremeties

•No scrotal/bipedal edema

6

ADMITTING DIAGNOSIS

T/C Acute Glomerulonephritis

7

COURSE IN THE WARD

1st HD low salt dietIVF: D5W x kvoDx’cs: CBC, PC, UA, 24hr-urine-chon, BUN, Crea, ASO, C3, KUB-UTZ

8

120/90mmHg

Tx’cs: Pen G, Paracetamol,Furosemide

Nifedipine, 5mg/cap, half cap/SL

COURSE IN THE WARD

9

COURSE IN THE WARD

2nd HD

Yellowish urine

IVF: D5 0.3%NaClOral fluids limited

(accdg.to BSA)

BSA (wt)4(9)/100 x 100

Furosemide IV shifted to p.o.

10

COURSE IN THE WARD

3rd HDu.o. = 0.8cc/24°/kg

4th HDu.o. = 0.9 cc/24°/kg

Furosemide ↑ q6°

11

COURSE IN THE WARD

6th HD DischargedHome meds: TMP-SMZ Furosemide x 3daysAscorbic acid

Advised repeat KUB-UTZ after 2 weeks

12

Urinalysis:

(4/19/10) (4/21/10) (4/25/10)

Color: dark yellow, turbid yellow, turbid yellow,sl.turbidpH: acidic acidic acidicsp.gr.: 1.010 1.010 1.010Albumin: +4 +4 traceRBC: loaded plenty 5-7WBC: 5-7 plenty 1-2

LABORATORY RESULTS

13

CBC (4/19/10) WBC 8.0 seg 0.89 lympho 0.30 eos 0.01

Hgb 110 hct 0.33 Platelet 232

LABORATORY RESULTS

14

(4/22/10) ASO 400IU/ml

C3 28.774 mg/L BUN 6.30

Crea 0.70 24°-urine-chon 793.8mg/ 24°

LABORATORY RESULTS

15

KUB-UTZ:

pelvicocaliectasia, rt kidney; left kidney & UB, normal

LABORATORY RESULTS

16

Acute glomerulonephritis (AGN)

is a disease characterized by the sudden appearance of edema, hematuria, proteinuria, and hypertension.

It is a representative disease of acute nephritic syndrome in which inflammation of the glomerulus is manifested by proliferation of cellular elements secondary to an immunological mechanism.

17

PATHOPHYSIOLOGY

Immune-complex disease

18

A schematic representation of the proposed mechanism for acute poststreptococcal glomerulonephritis (APSGN). C = Activated complement;

Pl = Plasmin; NAPlr = Nephritis-associated plasmin receptor; SK = Streptokinase; CIC = Circulating immune complex.

19

Normalization of urine sediment

Parameter

• Gross hematuria• Complement level• Proteinuria• Micro-hematuria

Resolved by

• 2-3 weeks• 6-8 weeks• 2-6 months• 6-12 months

20

TYPICAL COURSE

• Latent - few days to 3 weeks• oliguric – 7 to 10 days• diuretic – 7 to 10 days• convalescent – 7 to 10 days

21

CLINICAL & LABORATORY PROFILE

• hematuria (gross) 100%• proteinuria 86%• edema 85%• hypertension 82%• hypocomplementenemia 80%• cryoglobulinemia 63%• gen. malaise, weakness 55%• oliguria 52%• nausea & vomiting 15%• dull, lumbar pain 5%

22

ETIOLOGY

1. InfectionsBacterial: GABS, Strep. Viridans, strep.

Pneumoniae, S. aureus, S. epidermidis, T. pallidum, Leptospira, S. typhi

Viral: hep B, measles, mumps, CMV, enterovirus, GBS, onconavirus

Parasitic: toxoplasma, P. malariae, P, falciparum, schistosoma

Rickettsial: scrub typhusFungal: coccidioides immitis

23

2. Drugs: toxins, antisera, vaccines, DPT

3. Misc: tumor antigen, thyroglobulin, autologous Ig

ETIOLOGY

24

Group A Beta-hemolytic streptococcus (GABS) Nephritogenic strains

Sites: 1. Upper resp. tract: pharyngitis, M1, 2, 4, 12, 18, 252. Skin: pyoderma, M49, 55, 57, 603. Middle ear : rare

ETIOLOGY

25

LABORATORY DIAGNOSIS:

Urinalysis

• dec. volume & sp. gravity• casts (fine & granular)• hematuria (dysmorphic rbc)• proteinuria

26

Bacteriology/serology• culture of GABS• strp antibody titers – ASO

(pharyngitis) antiDNAse B (pyoderma), streptozyme

• serum complement – C3, generally dec. in acute phase, rises during convalescence, normal in 10% of cases


27

Renal function

• BUN, Crea – usually normal• In marked azotemia – metab.acidosis,

hyperK, hypoNa, inc. crea


28

• Hematology: +dilutional anemia, transient hypoalbuminemia

• Radiography: CXR – sunburst in congestion, renal utz


29

DIFFERENTIAL DIAGNOSES

• Low serum complement level• Systemic diseases• SLE (focal, 75%; diffuse, 90%)• Subacute bacterial endocarditis (90%)• Visceral abscess• "Shunt" nephritis (90%)• Cryoglobulinemia (58%)

30

• Renal diseases

• Acute postinfectious glomerulonephritis (>90%)

• MPGN - Type I (50-80%), type 2 (80-90%)

31


• Normal serum complement level• Systemic diseases• Polyarteritis nodosa group• Hypersensitivity vasculitis• Wegener granulomatosis• HSP• Goodpasture syndrome

32


• Renal diseases• IgA (or IgG-IgA) nephropathy• Idiopathic rapidly progressive

glomerulonephritis (RPGN)• Anti-glomerular basement membrane

(GBM) disease• Negative immunofluorescence findings• Immune complex disease

33


MANAGEMENT

Supportive & Symptomatic• bed rest, prn• fluid & salt restriction• Fluids: 400-600 ml/m2/day + UO 24h• NaCl ≤ 2g/day• K ≤ 40mEq/day

34

Antibiotics: • Penicillin 50000-100000 u/kg/d tid-qid x

10days

Specific interventions:• hypertension• CHF• Furosemide 2mg/kg/dose/IV• Dialysis: if refractory indications: uremia,

intractable hyperK, CHF

MANAGEMENT

35

NORMAL BP VALUES

Age

NB8-30days1 mo – 2 yrs2-5y6-11y>12y

Upper limit

95 mmHg, systolic

105115/75130/80135/85140/90

36

PROGNOSIS

• complete resolution • 5-10% progress to chronic state

37

Mortality Rate:

• 0-7% due to sepsis, CHF, hypertensive enceph

38

Consultation with a pediatric nephrologist isnecessary when one or more of the following arepresent:

• Severe hypertension• Severe oliguria• Severe edema• Nephrotic-range proteinuria• Azotemia (moderate to marked)• Recurrent episodes of gross hematuria• Persistently depressed C3 (past 8-10 wk)

39

Consultation with a pediatric nephrologist is necessary when one or more of the following are present:

Atypical onset

• Absence of latent period• No evidence of streptococcal illness

40

Failure of expected resolution of clinical signs• Gross hematuria within the preceding 10-14

days• Microscopic hematuria within 1 year• Edema within 2 weeks• Proteinuria (>50 mg/dL) within 6 months• Azotemia within 1 week• Hypertension within 6 weeks

41

Consultation with a pediatric nephrologist is necessary when one or more of the following are present:

FOLLOW-UP

Further Inpatient Care

Only a small percentage of patients with acute glomerulonephritis (AGN) require initial hospitalization, and most of those are ready for discharge in 2-4 days.

42

Further Inpatient Care

As soon as the blood pressure (BP) is under relatively good control and diuresis has begun, most children can be discharged and monitored as outpatients.

43

Further Outpatient CareFollow up at 0-6 weeks as frequently as

necessary to determine the following:Hypertension has been controlled.Edema has started to resolve.Gross hematuria has resolved.Azotemia has resolved.

.

44

Follow up 8-10 weeks after onset to determine the following:Azotemia has subsided.Anemia has been corrected.Hypertension has resolved.C3 and C4 concentrations have returned

to normal.

45

Follow up at 3, 6, and 9 months after onset to check the following:Hematuria and proteinuria are subsiding

gradually.BP is normal.

46

Follow up at 2, 5, and 10 years after onset to check the following:Urine is normal.BP is normal.Serum creatinine level is normal

47

Follow up at 12 months after onset to determine the following:Proteinuria has disappeared.Microscopic hematuria has disappeared.

48

Agn@rph case management

Health & Medicine

Transcript of Agn@rph case management